Welcome to MVA Oncology Network and our 2nd meeting!
Genmab is on everybody’s lips. Why is that and how did it come about? Medicon Valley Alliance member, Genmab, has a story to tell that is worth listening to for everybody interested in business and life science innovation in general and oncology in particular. That is why Medicon Valley Alliance as a regional life science cluster and networking organization dedicated to knowledge-sharing is happy to introduce Jan van de Winkel, CEO, Genmab as the key note speaker for the next Medicon Valley Alliance Oncology Network meeting.
Date: 30 January 2017
Time: 17:00 – 20:00
Host: Prof. Carl Borrebaeck, CREATE Health, Lund University
Venue: Auditorium, Medicon Village, Lund
Cost: Free of charge for MVA members
SIGN UP IS NOW CLOSED
MVA Oncology Network is a professional and social network within oncology. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region. The network consists of professors, PI and corporate level executives from the regional oncology eco-system. Membership is limited to Medicon Valley Alliance members only, but non-member organizations and companies are welcome to attend one network event to evaluate if a membership of the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically able you to join the oncology network.
The network meets three-four times a year and with agendas to be decided on an ongoing basis by the network participants. As a rule, the meetings will be hosted by the members of the network, and on special occasions by Medicon Valley Alliance. It is the ambition that the meetings will be hosted evenly on Danish and Swedish venues.
After the successful MVA Oncology Network Kick-off meeting in September, 2016, with more than 40 organizations participating, Medicon Valley Alliance, together with two of our members – Lund University and University of Copenhagen – now invites you to MVA Oncology Network and our 2nd meeting:
Program
|
17:00-17:30 |
Registration, networking and a bite to eat – meet the fellow participants |
| 17:30-17.35 | Welcome Helen Pettersson, Senior Project Manager, Medicon Valley Alliance Carl Borrebaeck, Prof., CREATE Health, Lund University Nils Brünner, Prof., University of Copenhagen |
| 17:35-18.00 | “Who are we?” 4 x 5 minute corporate presentations Lao Saal, CEO, SAGA Diagnostics AB Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB Lovisa Sunesson, Sales & BD, Bioneer A/S Peter Buhl Jensen, CEO, Oncology Venture AB |
| 18:00-18.15 | How to patent and publish Jens Viktor Nørgaard, Partner, HØIBERG |
| 18:15-18.20 | Introduction of keynote speaker and theme of the event Carl Borrebaeck, Prof., CREATE Health, Lund University |
| 18:20-19:05 | Keynote speaker and Q&A Genmab – Building an antibody innovation powerhouse |
 Jan van de Winkel, CEO, Genmab |
|
| 19:05-19:15 | Information platform for the network – mutual exchange of news, events, challenges etc. Date and program for 3rd meeting Helen Pettersson, Senior Project Manager, Medicon Valley Alliance |
| 19:15-20:00 | Structured networking and a light snack |
Sponsors
 |
 |
In collaboration
 |
 |
|
